Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis

Summary
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...
Description from Medpagetoday.
Who is covering this
-
Bulevirtide Linked to Less Decompensation in Chronic Hep D With Cirrhosis
(MedPage Today) -- In patients with chronic hepatitis delta (CHD) with cirrhosis, treatment with bulevirtide (Hepcludex) was associated with lower risk of liver decompensation, according to results from a European retrospective study. Among more...
Comments
Comments need JavaScript.